drugset / Trial / NCT00309855

Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men

NCT00309855

Phase 1 Completed 80 enrolled Mayo Clinic GlaxoSmithKline · collab
RandomizedCrossoverDouble-blindBasic science

Summary

This study is being done to understand how testosterone, the major male sex hormone, controls the pituitary gland's secretion of growth hormone (GH). GH is an important metabolic hormone, which controls sugar; fat and protein use in the body and maintains muscle strength and bone calcium content. Both testosterone and GH decline in older men. The age-related fall in these hormones probably contributes to relative frailty, reduced quality of life, bone loss, muscle wasting and impaired sexual function.

Timeline

Start
2005-12
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified Oral
Subject Dutasteride Small molecule Oral
Subject Testosterone Small molecule Intramuscular

Indications

No indication recorded.